Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
HutchMed's Orpathys Receives Priority Review for NSCLC Treatment in ...
HutchMed Completes Patient Enrollment for Orpathys in Gastric Cancer ...
HutchMed's Orpathys Approved in China for EGFR-MET Co-Mutation NSCLC ...
HutchMed's Orpathys Receives Breakthrough Therapy Designation in China ...
ORPATHYS and TAGRISSO combo approved in China for lung cancer ...
HutchMed Completes Patient Enrollment for Orpathys and Tagrisso ...
AstraZeneca, Hutchmed's Orpathys included in China's national ...
Orpathys (savolitinib) Effective in EGFR-Mutant, MET-Amplified Non ...
Hutchmed finalises enrolment for Orpathys and Tagrisso trial
Genetron, Hutchmed partner to develop diagnostic for Orpathys in China
HUTCHMED’ Orpathys (Savolitinib) Receives the NMPA’s Full Approval for ...
Orpathys approved in China for patients with lung cancer and MET gene ...
Hutchmed and AstraZeneca launch Phase 3 to test Orpathys and Tagrisso ...
Hutchmed Seeking Additional Approval in China for Orpathys in MET Exon ...
NMPA approves ORPATHYS + TAGRISSO combo in China for the Treatment of ...
AstraZeneca's Orpathys approved in China - Nordic Life Science – the ...
Haihe takes on Orpathys in China | ApexOnco - Clinical Trials news and ...
ORPATHYS (Savolitinib Tablets) - NSCLC | DengYue Medicine
HUTCHMED
We are pleased to announce that the supplemental New Drug Application ...
沃瑞沙/ORPATHYS说明书_医药百科_医库
HUTCHMED Receives Approval for ORPATHYS® and TAGRISSO® Combination in ...
We are pleased to share that the New Drug Application for the ...
HUTCHMED Gains China Approval for ORPATHYS® and TAGRISSO® Combo in MET ...
HUTCHMED Announces Breakthrough Therapy Designation for ORPATHYS® and ...
Hutchmed Completes Patient Enrollment for Orpathys®-Tagrisso® Lung ...
HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high ...
HUTCHMED Completes Patient Enrollment in Phase III SANOVO Study of ...
HUTCHMED's ORPATHYS®: A Game Changer in MET Exon 14 NSCLC Treatment
HutchMed highlights publication of Phase III SACHI study results of ...
HUTCHMED - 上市产品
Hutchmed's Orpathys, Tagrisso NSCLC Combo Approved in China | Precision ...
HUTCHMED Announces China Approval for ORPATHYS® in Combination with ...
HUTCHMED's ORPATHYS® and TAGRISSO® Combo: A Game Changer in Lung Cancer ...
China’s NMPA prioritises HUTCHMED’s lung cancer therapy review
We are pleased to announce positive high-level results from the ...
HUTCHMED - HUTCHMED Reports 2025 Interim Results
HUTCHMED completes enrolment in phase 3 trial for lung cancer - Pharmafile
HUTCHMED - HUTCHMED Reports 2024 Full Year Results and Provides ...
Insight, China's Pharmaceutical Industry - Fineline Info & Tech
HUTCHMED on LinkedIn: HUTCHMED Announces Agreement with NHSA for ...
HUTCHMED's Savolitinib Advances for Expanded Approval in China ...
We are pleased to share that the Center for Drug Evaluation of China’s ...
Drug Establishments Current Registration Site
AZ, HutchMed's savolitinib gets 1st approval in China for NSCLC ...
肺癌精准治疗！中国MET抑制剂：赛沃替尼(沃瑞沙，Orpathys)获批，治疗METex14突变非小细胞肺癌! - 专区 - 生物谷
NMPA grants priority review for HUTCHMED’s NSCLC combo
Trinity Delta Orpathys/Tagrisso combination approved in China - Trinity ...
Obstructive Uropathy Explained: From Symptoms to Treatment - YouTube
Anticancer drugs: How to select small molecule combinations?: Trends in ...
HUTCHMED - HUTCHMED Reports 2023 Full Year Results and Provides ...
Massive Bio: Advancing Cancer Care with AI-Driven Clinical Trials
Causes Of Hydronephrosis
和黄医药宣布沃瑞沙(ORPATHYS)于中国首次商业销售 触发来自阿斯利康的2,500万美元里程碑付款医药新闻-ByDrug-一站式医药资源 ...
Hutchmed completes Saffron trial enrolment, results due 2026 ...
Savolitinib Shines in HutchMed Phase II Lung Cancer Trial
NDA in China receives priority review status for lung cancer treatment
HUTCHMED on LinkedIn: We are delighted to announce the first commercial ...
Urinary Tract Obstruction Obstructive Uropathy | PDF | Kidney | Medical ...
Obstructive Uropathy "online" | PPTX
Trinity Delta Looking ahead to the next chapter - Trinity Delta
和黄医药宣布沃瑞沙® (ORPATHYS®) 和泰瑞沙® (TAGRISSO®) 的联合疗法用于治疗伴有MET扩增的一线EGFR抑制剂治疗后 ...
和黄医药(00013.HK)宣布沃瑞沙(ORPATHYS)和泰瑞沙(TAGRISSO)的联合疗法在中国获纳入突破性治疗品种用于治疗EGFR抑制 ...
Obstructive Uropathy | PPTX
Obstructive Uropathy of Urology | PPT
SOLUTION: Urosurgery obstructive uropathy - Studypool
Obstructive Uropathy: A video of urinary tract blockage | Science ...
Trinity Delta On the right track - Trinity Delta
Obstructive Uropathy | PDF | Medical Specialties | Clinical Medicine
Pathophysiology and causes of obstructive Uropathy .pptx
(PDF) A review of the current treatment methods for retroperitoneal ...
Obstructive Uropathy - Assignment Point
Obstructive Uropathy.pptx
Savolitinib in patients in China with locally advanced or metastatic ...
obstructive uropathy.pptx
OBSTRUCTIVE UROPATHY PPT.pptx
HUTCHMED - 《柳叶刀 · 呼吸医学》：赛沃替尼治疗MET 外显子14 跳跃突变的中国非小细胞肺癌患者
Case 81: Bilateral Ureteric Calculi Causing Obstructive Uropathy ...
Antioxidant, Anti-Apoptotic, and Anti-Inflammatory Effects of Farrerol ...
Acute Obstructive Uropathy with AKI in a young patient managed ...
Urinary Retention Vs Obstructive Uropathy - Dr Samarth Agarwal
Ketamine-induced uropathy | Eurorad
PPT - Obstructive uropathies PowerPoint Presentation, free download ...
Hutchmed cashes in a Chinese JV to help fund its pipeline | pharmaphorum
Obstructive uropathy | Radiology Case | Radiopaedia.org
Heather Reinhardt Hays, CPB on LinkedIn: HUTCHMED and AstraZeneca ...
Obstructive Uropathy - MD Searchlight
Obstructive uropathy: Causes, symptoms, and treatment
Urology & Continence Care Today - Article: Ketamine uropathy - Urology ...
Obstructive uropathy in neonates | PPTX
Ketamine uropathy - CLP Hub
Management of Obstructive Uropathy: Anatomy, Symptoms, Differential ...
00211-X%2Fasset%2F4720b183-ea73-4d44-9a18-b3ffd194efc4%2Fmain.assets%2Fgr2_lrg.jpg&w=3840&q=75)
